References
- WangJWangRLiLBPreparation and properties of hydroxycamptothecin-loaded nanoparticles made of amphiphilic copolymer and normal polymerJ Colloid Interface Sci2009336280881319520376
- PuXSunJWangYDevelopment of a chemically stable 10-hydroxycamptothecin nanosuspensionInt J Pharm2009379116717319505545
- ErtlBPlatzerPWirthMGaborFPoly (D,L-lactic-co-glycolic acid) microspheres for sustained delivery and stabilization of camptothecinJ Control Release199961330531710477803
- ShenderovaABurkeTGSchwendemanSPStabilization of 10-hydroxycamptothecin in poly (lactide-co-glycolide) microsphere delivery vehiclesPharm Res19971410140614149358554
- O’LearyJMuggiaFMCamptothecins: a review of their development and schedules of administrationEur J Cancer19983410150015089893620
- HongMZhuSJiangYYTangGTPeiYYEfficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferringJ Control Release200913329610218840485
- YangXLiLWangYTanYPreparation, pharmacokinetics and tissue distribution of micelles made of reverse thermo-responsive polymersInt J Pharm20093701–221021519114094
- ZhangCDingYYuLLPingQPolymeric micelle systems of hydroxycamptothecin based on amphiphilic N-alkyl-N-trimethyl chitosan derivativesColloids Surf B Biointerfaces200755219219917223019
- MinKHParkKKimYSHydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapyJ Control Release2008127320821818336946
- RubinoOPKowalskyRSwarbrickJAlbumin microspheres as a drug delivery system: relation among turbidity ratio, degree of cross-linking, and drug releasePharm Res1993107105910658378248
- OpanasopitPYokoyamaMWatanabeMKawanoKMaitaniYOkanoTInfluence of serum and albumins from different species on stability of camptothecin-loaded micellesJ Control Release2005104231332115907582
- FranklinWAWaintrubMEdwardsDNew anti-lung-cancer antibody cluster 12 reacts with human folate receptors present on adenocarcinomaInt J Cancer Suppl199457889958194901
- WeitmanSDLarkRHConeyLRDistribution of the folate receptor GP38 in normal and malignant cell lines and tissuesCancer Res19925212339634011596899
- LeamonCPCooperSRHardeeGEFolate-liposome-mediated antisense oligonucleotide targeting to cancer cells: evaluation in vitro and in vivoBioconjug Chem200314473874712862426
- ZhaoXHZuYGLiQYPreparation and characterization of camptothecin powder micronized by a supercritical antisolvent (SAS) processJ Supercrit Fluids2010513412419
- LeamonCPLowPSDelivery of macromolecules into living cells: a method that exploits folate receptor endocytosisProc Natl Acad Sci U S A19918813557255762062838
- KimSHKimJKLimSJParkJSLeeMKKimCKFolate-tethered emulsion for the target delivery of retinoids to cancer cellsEur J Pharm Biopharm200868361862517949957
- DosioFArpiccoSStellaBBrusaPCattelLFolate-mediated targeting of albumin conjugates of paclitaxel obtained through a heterogeneous phase systemInt J Pharm20093821–211712319712735
- ZhaoDMZhaoXHZuYGPreparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticlesInt J Nanomedicine2010566967720957218
- ZhangYDGongLSPreparation of amycin loading magnetic albumin nanoparticlesJ China Modern Med20011113
- SuHHuJHLiFQPreparation process and target progress of albumin nanoparticlesJ Chin Pharm200540641644
- ZhangLHouSMaoSWeiDSongXLuYUptake of folate-conjugated albumin nanoparticles to the SKOV3 cellsInt J Pharm20042871–215516215541922
- HanXLiuMXieC9-NC-loaded folate-conjugated polymer micelles as tumor targeted drug delivery system: preparation and evaluation in vitroInt J Pharm20093721–212513119166923
- ChoKWangXNieSChenZGShinDMTherapeutic nanoparticles for drug delivery in cancerClin Cancer Res20081451310131618316549
- WartlickHMichaelisKBalthasarSStrebhardtKKreuterJLangerKHighly specific HER2-mediated cellular uptake of antibody-modified nanoparticles in tumour cellsJ Drug Target200412746147115621671
- AtkinsonSFBettingerTSeymourLWBehrJPWardCMConjugation of folate via gelonin carbohydrate residues retains ribosomal-inactivating properties of the toxin and permits targeting to folate receptor positive cellsJ Biol Chem200127630279302793511359781
- MartyJJOppenheimRCSpeiserPNanoparticles – a new colloidal drug delivery systemPharm Acta Helv19785311723643885
- LiFQSuHWangJPreparation and characterization of sodium ferulate entrapped bovine serum albumin nanoparticles for liver targetingInt J Pharm20083491–227428217870261
- MerodioMArnedoARenedoMJIracheJMGanciclovir-loaded albumin nanoparticles: characterization and in vitro release propertiesEur J Pharm Sci200112325125911113644
- ZuYZhangYZhaoXZhangQLiuYJiangROptimization of the preparation process of vinblastine sulfate (VBLS)-loaded folate-conjugated bovine serum albumin (BSA) nanoparticles for tumor-targeted drug delivery using response surface methodology (RSM)Int J Nanomedicine2009432133320054435
- YangLCuiFCunDTaoAShiKLinWPreparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticlesInt J Pharm20073401–216317217482779
- MüllerBGLeuenbergerHKisselTAlbumin nanospheres as carriers for passive drug targeting: an optimized manufacturing techniquePharm Res199613132378668675
- HuangSJSunSLFengTHSungKHLuiWLWangLFFolate-mediated chondroitin sulfate-Pluronic 127 nanogels as a drug carrierEur J Pharm Sci2009381647319540339
- BeckRCPohlmannARHoffmeisterCDexamethasone-loaded nanoparticle-coated microparticles: correlation between in vitro drug release and drug transport across Caco-2 cell monolayersEue J Pharm Biopharm20076711830
- EskandarNGSimovicSPrestidgeCAChemical stability and phase distribution of all-trans-retinol in nanoparticle-coated emulsionsInt J Pharm20093761–218619419422895
- GillCSPriceBAJonesCWSulfonic acid-functionalized silica-coated magnetic nanoparticle catalystsJournal of Catalysis20072511145152
- GuptaPKHungCTPerrierDGAlbumin microspheres. I. Release characteristics of adriamycinInt J Pharm1986331–3137146
- RubinoOPKowalskyRSwarbrickJAlbumin microspheres as a drug delivery system: relation among turbidity ratio, degree of cross-linking, and drug releasePharm Res1993107105910658378248
- WeberCCoesterCKreuterJLangerKDesolvation process and surface characterisation of protein nanoparticlesInt J Pharm200019419110210601688
- KamenBAWangMTStreckfussAJPeryeaXAndersonRGDelivery of folates to the cytoplasm of MA104 cells is mediated by a surface membrane receptor that recyclesJ Biol Chem19882632713602136093417674